Cargando…
Intentions of Patients with Hypertension to Receive a Booster Dose of the COVID-19 Vaccine: A Cross-Sectional Survey in Taizhou, China
COVID-19 patients with hypertension have increased hospital complications and mortality rates. Moreover, these patients also have lower antibody titers after receiving the coronavirus disease (COVID-19) vaccine. Therefore, patients with hypertension should receive a COVID-19 vaccine booster. To prom...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608070/ https://www.ncbi.nlm.nih.gov/pubmed/36298500 http://dx.doi.org/10.3390/vaccines10101635 |
_version_ | 1784818694660030464 |
---|---|
author | Ying, Chen-Qian Lin, Xiao-Qing Lv, Li Chen, Yan Jiang, Jian-Jun Zhang, Yun Tung, Tao-Hsin Zhu, Jian-Sheng |
author_facet | Ying, Chen-Qian Lin, Xiao-Qing Lv, Li Chen, Yan Jiang, Jian-Jun Zhang, Yun Tung, Tao-Hsin Zhu, Jian-Sheng |
author_sort | Ying, Chen-Qian |
collection | PubMed |
description | COVID-19 patients with hypertension have increased hospital complications and mortality rates. Moreover, these patients also have lower antibody titers after receiving the coronavirus disease (COVID-19) vaccine. Therefore, patients with hypertension should receive a COVID-19 vaccine booster. To promote the uptake of COVID-19 vaccine booster among hypertensive patients, this study investigated patients’ willingness and factors that influence patients with hypertension to receive the COVID-19 vaccine booster. From July 2021 to August, 410 patients with hypertension were surveyed. Overall, 76.8% of patients were willing to receive the COVID-19 vaccine booster, as 82.7% of patients without comorbidities and 72.7% of patients with comorbidities were willing to receive the vaccine booster. The main factors that influenced the willingness of patients with hypertension to receive a booster dose were the preventive effect of the vaccine (χ(2) = 52.827, p < 0.05), vaccine safety (χ(2) = 42.423, p < 0.05), vaccine knowledge (χ(2) = 7.831, p < 0.05), presence of comorbidities (χ(2) = 4.862, p < 0.05), disease control (χ(2) = 5.039, p < 0.05), and antihypertensive treatments (χ(2) = 12.565, p < 0.05). This study’s findings highlight the need to promote knowledge about booster vaccination among patients and health management. These measures would improve patients’ willingness and knowledge about the vaccine and their health status, which are the main factors that influence patients’ intention to receive booster vaccines. |
format | Online Article Text |
id | pubmed-9608070 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96080702022-10-28 Intentions of Patients with Hypertension to Receive a Booster Dose of the COVID-19 Vaccine: A Cross-Sectional Survey in Taizhou, China Ying, Chen-Qian Lin, Xiao-Qing Lv, Li Chen, Yan Jiang, Jian-Jun Zhang, Yun Tung, Tao-Hsin Zhu, Jian-Sheng Vaccines (Basel) Article COVID-19 patients with hypertension have increased hospital complications and mortality rates. Moreover, these patients also have lower antibody titers after receiving the coronavirus disease (COVID-19) vaccine. Therefore, patients with hypertension should receive a COVID-19 vaccine booster. To promote the uptake of COVID-19 vaccine booster among hypertensive patients, this study investigated patients’ willingness and factors that influence patients with hypertension to receive the COVID-19 vaccine booster. From July 2021 to August, 410 patients with hypertension were surveyed. Overall, 76.8% of patients were willing to receive the COVID-19 vaccine booster, as 82.7% of patients without comorbidities and 72.7% of patients with comorbidities were willing to receive the vaccine booster. The main factors that influenced the willingness of patients with hypertension to receive a booster dose were the preventive effect of the vaccine (χ(2) = 52.827, p < 0.05), vaccine safety (χ(2) = 42.423, p < 0.05), vaccine knowledge (χ(2) = 7.831, p < 0.05), presence of comorbidities (χ(2) = 4.862, p < 0.05), disease control (χ(2) = 5.039, p < 0.05), and antihypertensive treatments (χ(2) = 12.565, p < 0.05). This study’s findings highlight the need to promote knowledge about booster vaccination among patients and health management. These measures would improve patients’ willingness and knowledge about the vaccine and their health status, which are the main factors that influence patients’ intention to receive booster vaccines. MDPI 2022-09-29 /pmc/articles/PMC9608070/ /pubmed/36298500 http://dx.doi.org/10.3390/vaccines10101635 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ying, Chen-Qian Lin, Xiao-Qing Lv, Li Chen, Yan Jiang, Jian-Jun Zhang, Yun Tung, Tao-Hsin Zhu, Jian-Sheng Intentions of Patients with Hypertension to Receive a Booster Dose of the COVID-19 Vaccine: A Cross-Sectional Survey in Taizhou, China |
title | Intentions of Patients with Hypertension to Receive a Booster Dose of the COVID-19 Vaccine: A Cross-Sectional Survey in Taizhou, China |
title_full | Intentions of Patients with Hypertension to Receive a Booster Dose of the COVID-19 Vaccine: A Cross-Sectional Survey in Taizhou, China |
title_fullStr | Intentions of Patients with Hypertension to Receive a Booster Dose of the COVID-19 Vaccine: A Cross-Sectional Survey in Taizhou, China |
title_full_unstemmed | Intentions of Patients with Hypertension to Receive a Booster Dose of the COVID-19 Vaccine: A Cross-Sectional Survey in Taizhou, China |
title_short | Intentions of Patients with Hypertension to Receive a Booster Dose of the COVID-19 Vaccine: A Cross-Sectional Survey in Taizhou, China |
title_sort | intentions of patients with hypertension to receive a booster dose of the covid-19 vaccine: a cross-sectional survey in taizhou, china |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608070/ https://www.ncbi.nlm.nih.gov/pubmed/36298500 http://dx.doi.org/10.3390/vaccines10101635 |
work_keys_str_mv | AT yingchenqian intentionsofpatientswithhypertensiontoreceiveaboosterdoseofthecovid19vaccineacrosssectionalsurveyintaizhouchina AT linxiaoqing intentionsofpatientswithhypertensiontoreceiveaboosterdoseofthecovid19vaccineacrosssectionalsurveyintaizhouchina AT lvli intentionsofpatientswithhypertensiontoreceiveaboosterdoseofthecovid19vaccineacrosssectionalsurveyintaizhouchina AT chenyan intentionsofpatientswithhypertensiontoreceiveaboosterdoseofthecovid19vaccineacrosssectionalsurveyintaizhouchina AT jiangjianjun intentionsofpatientswithhypertensiontoreceiveaboosterdoseofthecovid19vaccineacrosssectionalsurveyintaizhouchina AT zhangyun intentionsofpatientswithhypertensiontoreceiveaboosterdoseofthecovid19vaccineacrosssectionalsurveyintaizhouchina AT tungtaohsin intentionsofpatientswithhypertensiontoreceiveaboosterdoseofthecovid19vaccineacrosssectionalsurveyintaizhouchina AT zhujiansheng intentionsofpatientswithhypertensiontoreceiveaboosterdoseofthecovid19vaccineacrosssectionalsurveyintaizhouchina |